Table 1 Baseline characteristics of participants prior to randomisation
Tranexamic acid | Placebo | |
|---|---|---|
(n = 10,000) | (n = 10,000) | |
Age at randomisation (years): | ||
< 16 | N (X %) | N (X %) |
16–25 | N NNN (X %) | N NNN (X %) |
26–33 | N NNN (X %) | N NNN (X %) |
34+ | N NNN (X %) | N NNN (X %) |
Baby delivered in this hospital | N NNN (X %) | N NNN (X %) |
Type of delivery: | ||
Vaginal | N NNN (X %) | N NNN (X %) |
Caesarean section | N NNN (X %) | N NNN (X %) |
Time between delivery and randomisation (hours): | ||
≤ 1 | N NNN (X %) | N NNN (X %) |
> 1 to ≤ 3 | N NNN (X %) | N NNN (X %) |
> 3a | N NNN (X %) | N NNN (X %) |
Placenta fully delivered: | ||
Yes | N NNN (X %) | N NNN (X %) |
No | NNN (X %) | NNN (X %) |
Primary cause of haemorrhage: | ||
Uterine atony | N NNN (X %) | N NNN (X %) |
Placenta praevia/accreta | N NNN (X %) | N NNN (X %) |
Surgical trauma/tears | N NNN (X %) | N NNN (X %) |
Other | N NNN (X %) | N NNN (X %) |
Unknown | N NNN (X %) | N NNN (X %) |
Systolic BP (mmHg): | ||
≥ 90 | N NNN (X %) | N NNN (X %) |
< 90 | N NNN (X %) | N NNN (X %) |
Estimated volume of blood lost (mL): | ||
≤ 500 | N NNN (X %) | N NNN (X %) |
> 500 to ≤ 1000 | N NNN (X %) | N NNN (X %) |
> 1000 | N NNN (X %) | N NNN (X %) |
Uterotonic prophylaxis given: | ||
Yes | N NNN (X %) | N NNN (X %) |
No | N NNN (X %) | N NNN (X %) |
Not known | N NNN (X %) | N NNN (X %) |
Clinical signs of haemodynamic instability: | ||
Yes | N NNN (X %) | N NNN (X %) |
No | N NNN (X %) | N NNN (X %) |